These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6697434)

  • 1. Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide.
    Williams GM; Furuya K
    Carcinogenesis; 1984 Feb; 5(2):171-4. PubMed ID: 6697434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoplastic conversion in rat liver by the antihistamine methapyrilene demonstrated by a sequential syncarcinogenic effect with N-2-fluorenylacetamide.
    Furuya K; Williams GM
    Toxicol Appl Pharmacol; 1984 Jun; 74(1):63-9. PubMed ID: 6729822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of various chemicals on the development of hyperplastic liver nodules in hepatectomized rats treated with N-nitrosodiethylamine or N-2-fluorenylacetamide.
    Ito N; Tatematsu M; Nakanishi K; Hasegawa R; Takano T; Imaida K; Ogiso T
    Gan; 1980 Dec; 71(6):832-42. PubMed ID: 7274629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of a promoting or sequential syncarcinogenic effect in rat liver by the carcinogenic hypolipidemic drug nafenopin given after N-2-fluorenylacetamide.
    Numoto S; Mori H; Furuya K; Levine WG; Williams GM
    Toxicol Appl Pharmacol; 1985 Jan; 77(1):76-85. PubMed ID: 3966244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic cell loss and proliferation induced by N-2-fluorenylacetamide, diethylnitrosamine, and aflatoxin B1 in relation to hepatoma induction.
    Nishizumi M; Albert RE; Burns FJ; Bilger L
    Br J Cancer; 1977 Aug; 36(2):192-7. PubMed ID: 199226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice.
    Ward JM; Rice JM; Creasia D; Lynch P; Riggs C
    Carcinogenesis; 1983 Aug; 4(8):1021-9. PubMed ID: 6872148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent induction of preneoplastic liver cell foci by 2-acetylaminofluorene, phenobarbital and acetaminophen in F344 rats initially treated with diethylnitrosamine.
    Hasegawa R; Takahashi S; Imaida K; Yamaguchi S; Shirai T; Ito N
    Jpn J Cancer Res; 1991 Mar; 82(3):293-7. PubMed ID: 1902451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites.
    Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J
    Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of hepatocarcinogenesis by sequential administration of chemicals: summation versus promotion effects.
    Williams GM; Katayama S; Ohmori T
    Carcinogenesis; 1981; 2(11):1111-7. PubMed ID: 6119166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of rapid initiating, promoting or sequential syncarcinogenic effects of di(2-ethylhexyl)phthalate in rat liver carcinogenesis.
    Williams GM; Maruyama H; Tanaka T
    Carcinogenesis; 1987 Jul; 8(7):875-80. PubMed ID: 3594721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer activity in a medium-term multi-organ bioassay for carcinogenesis.
    Spinardi AL; Kaneno R; Rodrigues MA; Salvadori DM; Rocha NS; Barbisan LF; Ribeiro LR; de Camargo JL
    Jpn J Cancer Res; 1999 Jan; 90(1):101-7. PubMed ID: 10076572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of hyperplastic liver nodules in hepatectomized rats treated with 3'-methyl-4-dimethylaminoazobenzene, benzo[a]pyrene or phenobarbital before or after exposure to N-2-fluorenylacetamide.
    Hasegawa R; Tatematsu M; Tsuda H; Shirai T; Hagiwara A; Ito N
    Gan; 1982 Apr; 73(2):264-9. PubMed ID: 6288500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological alterations and DNase deficiency in phenobarbital promotion of N-nitrosomorpholine initiated rat hepatocarcinogenesis.
    Taper HS; Lans M; de Gerlache J; Fort L; Roberfroid M
    Carcinogenesis; 1983; 4(2):231-4. PubMed ID: 6825212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mode of action of four hepatocarcinogens: a model-based approach.
    Groos J; Bannasch P; Schwarz M; Kopp-Schneider A
    Toxicol Sci; 2007 Oct; 99(2):446-54. PubMed ID: 17636249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influences of different polychlorinated biphenyls on cytocidal, mitoinhibitory, and nodule-selecting activities of N-2-fluorenylacetamide in rat liver.
    Hayes MA; Roberts E; Safe SH; Farber E; Cameron RG
    J Natl Cancer Inst; 1986 Apr; 76(4):683-91. PubMed ID: 2870208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the development of N-nitrosomorpholine-induced hepatic lesions by 2-acetylaminofluorene, phenobarbital and 4,4'-diaminodiphenylmethane: a sequential histological and histochemical analysis.
    Ito N; Moore MA; Bannasch P
    Carcinogenesis; 1984 Mar; 5(3):335-42. PubMed ID: 6705139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of trans-4-acetylaminostilbene and 2-acetylaminofluorene at the level of tumor initiation.
    Hammerl R; Kirchner T; Neumann HG
    Chem Biol Interact; 1994 Oct; 93(1):11-28. PubMed ID: 7915206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short term induction of preneoplastic nodules in the rat liver. I. The role of 2-AAF as selecting agent.
    van der Heijden CA; Dormans JA; van Nesselrooij JH
    Eur J Cancer (1965); 1980 Nov; 16(11):1389-98. PubMed ID: 7227415
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of azathioprine and carbon tetrachloride on induction of hyperplastic liver nodule and hepatocellular carcinoma by diethylnitrosamine and N-2-fluorenylacetamide in rats.
    Sakata T; Watanabe A; Takei N; Shiota T; Nakatsukasa H; Fujiwara M; Kobayashi M; Nagashima H
    Ann N Y Acad Sci; 1983; 417():288-93. PubMed ID: 6142675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced liver tumor promotion activity in rats subjected to combined administration of phenobarbital and orphenadrine.
    Morita R; Yafune A; Shiraki A; Itahashi M; Akane H; Nakane F; Suzuki K; Shibutani M; Mitsumori K
    J Toxicol Sci; 2013; 38(3):415-24. PubMed ID: 23665940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.